Viatris Inc is recalling approximately 22,400 syringes of Octreotide Acetate Injection (500 mcg/mL) due to a report of glass particles being found inside a syringe. This prescription medication is a single-dose injectable used for treating certain hormonal and digestive conditions. To date, no injuries or adverse events have been reported in connection with this recall.
Injecting a solution containing glass particles can cause localized irritation, swelling, or inflammation at the injection site. If the particles enter the bloodstream, they could potentially travel to and damage vital organs like the heart, lungs, or brain, which may result in serious health complications or life-threatening injuries.
Manufactured for Mylan Institutional LLC; 10 x 1 mL syringes per carton.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.